Wave Life Sciences, Inc.: shareholders and insiders

WVENASDAQHealthcare · Pharmaceutical Preparations

Price

$2.72

November 19, 2026Market cap $523M

What Ploutos Investor adds for Wave Life Sciences

Part of Ploutos Investor, €9.99 a month

See the plans
  • The full history: 11 fiscal years, from 2015
  • The estimated fair value, with its range and its certainty
  • The full analysis, 18 a month
  • More questions to the chat on its filings
  • Excel with every year
  • An email when it reports, changes its dividend or an officer buys

Sign in with a free account to see the last 5 fiscal years.

Insiders and their shares

Purchases and sales by officers and directors from Nov 20, 2025 to Oct 7, 2026, from their own Form 4 filings.

12 Form 4s

Bought on the market

$83M

2 people

Sold on the market

$16M

11 people

From Nov 20, 2025 to Nov 20, 2026, the days the chart shows. Change its range and the figures follow.

How the sales were made, as a share of their value

  • Under a set plan98%
  • The rest2%

By year

Insiders' open-market purchases (up) and sales (down), by value, since Nov 20, 2025, on a log scale: each gridline is ten times the last. From the SEC's quarterly data sets of Form 4 filings.

2026·bought $55M by 1 person·sold $1.0M by 8 people

  • 2025: bought $28M by 1 person, sold $15M by 8 people
  • 2026: bought $55M by 1 person, sold $1.0M by 8 people
  • Oct 5, 2026Ra Capital Management, L.p.Director
    Kind
  • Oct 5, 2026Gregory L. VerdineDirector
    Kind
  • Oct 5, 2026Aik Na TanDirector
    Kind
  • Oct 5, 2026Ken TakanashiDirector
    Kind
  • Oct 5, 2026Mark CorriganDirector
    Kind
  • Oct 5, 2026Adrian RawcliffeDirector
    Kind
  • Oct 5, 2026Heidi L WagnerDirector
    Kind
  • Oct 5, 2026Christian O HenryDirector
    Kind
  • Aug 12, 2026Adrian RawcliffeDirector
    Kind10b5-1
  • Aug 11, 2026Heidi L WagnerDirector
    Kind10b5-1
  • Aug 11, 2026Heidi L WagnerDirector
    Kind10b5-1
  • Aug 11, 2026Ken TakanashiDirector
    Kind10b5-1
  • Aug 11, 2026Aik Na TanDirector
    Kind10b5-1
  • Mar 30, 2026Ra Capital Management, L.p.
    Kind
  • Mar 27, 2026Ra Capital Management, L.p.
    Kind
  • Mar 26, 2026Ra Capital Management, L.p.
    Kind
  • Mar 26, 2026Ra Capital Management, L.p.
    Kind
  • Feb 26, 2026Chris Francis
    Kind10b5-1
  • Feb 26, 2026Chris Francis
    Kind10b5-1
  • Feb 9, 2026Chandra Vargeese
    Kind
  • Feb 9, 2026Chris Francis
    Kind
  • Feb 9, 2026Paul BolnoPresident and CEO
    Kind
  • Feb 9, 2026Kyle MoranChief Financial Officer
    Kind
  • Jan 2, 2026Chris Francis
    Kind10b5-1
  • Jan 2, 2026Chris Francis
    Kind10b5-1

From the Form 4s insiders file with the SEC within two business days of each trade. Before Aug 13, 2026 the table lists open-market purchases and sales only (no grants, option exercises or tax withholding), from the SEC's quarterly data sets. The 10b5-1 mark comes from the form's own box (since April 2023) or from a footnote of the filing that names the plan, where there is one.

Insiders and their shares

Every buy and sale by WVE's officers and directors from 2015 up to November 19, 2025, 11 more calendar years

Part of Ploutos Investor, €9.99 a month

See the plans

Sign in with a free account to see the last 3 years.

Major holders (over 5%)

Whoever comes to own more than 5% of a class of shares reports it to the SEC on Schedule 13D or 13G. Here is each holder's latest filing.

4 Holders over 5%2 On a 13DOct 27, 2026 Latest filing
  • RA Capital Management, L.P.with 3 more persons
    Share of class17.1%
  • RA Capital Management, L.P.with 3 more persons
    Share of class16.8%
  • BlackRock, Inc.
    Share of class6.80%
  • Maverick Capital, Ltd.with 2 more persons$0 Par Value Ordinary Shares
    Share of class5.40%

What the holders on a 13D state as their purpose

From Item 4 of the filing, in the holder's own words. It is the intention the holder states, not something that happened.

  • RA Capital Management, L.P.17.1%From the filing of Apr 17, 2026

    Item 4 of the Statement is hereby amended and supplemented as follows: On April 15, 2026, the Issuer into an Implementation Agreement, dated as of April 15, 2026 (the "Implementation Agreement"), with a newly established Delaware corporation, Wave Life Sciences, Inc. ("Wave-Delaware"). The Implementation Agreement provides for a statutory procedure known as a Scheme of Arrangement (the "Scheme of Arrangement") to be implemented by the Issuer and Wave-Delaware under Singapore law, subject to approval of the High Court of the Republic of Singapore (the "Singapore Court"). Pursuant to the Scheme of Arrangement, all issued ordinary shares in the capital of the Issuer as of immediately prior to…

    From the filing of Apr 17, 2026
  • RA Capital Management, L.P.16.8%From the filing of Aug 11, 2026

    Item 4 of the Statement is hereby amended and supplemented as follows: On August 7, 2026, as part of the Redomiciliation, Wave-Delaware, became the ultimate parent company of the Wave Life Sciences group of companies. Pursuant to the Scheme of Arrangement, all issued ordinary shares in the capital of Wave Life Sciences Ltd. ("Wave-Singapore") as of immediately prior to the effective time of the Scheme of Arrangement were exchanged on a one-for-one basis for newly issued shares of common stock, par value $0.001 per share, of Wave-Delaware, and Wave-Singapore became a wholly owned subsidiary of Wave-Delaware.

    From the filing of Aug 11, 2026
Fell to 5% or less (3)

Holders whose latest filing says they hold 5% or less. After it they need not file again, so what they hold today is not known.

  • BlackRock, Inc.0.00%Oct 27, 202613G/A
  • Adage Capital Management, L.P.0.53%May 13, 202613G/A
  • FMR2.80%May 6, 202613G/A

From the Schedule 13D and 13G filed with the SEC since Dec 18, 2024, when they became structured data. A holder who has filed nothing since then is not shown here. A 13D is updated within two business days of any material change, a 13G up to 45 days after the quarter of the change, so the shares are those of the filing. The large managers also appear in the 13Fs.

Well-known managers

Which of the about 30 investment managers we track held the shares at the quarter end, and what they changed from the quarter before.

Sep 30, 2026 quarter end
  • Duquesne (Druckenmiller)
    In the quarter
  • Point72 (Cohen)
    In the quarter
  • D.E. Shaw
    In the quarter
  • Renaissance Technologies
    In the quarter
  • Citadel Advisors (Griffin)
    In the quarter
  • Millennium Mgmt (Englander)
    In the quarter
  • AQR Capital
    In the quarter

From the 13Fs managers file with the SEC up to 45 days after each quarter end. They show only long positions on that day, not short sales or what has changed since. No recent 13F: Pershing Square (Ackman), Scion (Burry).

Short interest

How many of the company's shares have been sold borrowed and not yet bought back, twice a month.

On Oct 15, 2026, 11.0% of its shares outstanding were held short, +14.1% since the report before.

Shares held short
21.17M
11.0%
Since the report before18.56M on Sep 30, 2026
+14.1%
6.5
3.24M
More days to cover thanof 4,578 US-listed companies with enough volume
75%
Report date
Oct 15, 2026
  • Oct 31, 2023: Shares held short 3.59M
  • Nov 15, 2023: Shares held short 3.48M
  • Nov 30, 2023: Shares held short 3.26M
  • Dec 15, 2023: Shares held short 3.20M
  • Dec 29, 2023: Shares held short 3.18M
  • Jan 12, 2024: Shares held short 3.22M
  • Jan 31, 2024: Shares held short 2.96M
  • Feb 15, 2024: Shares held short 2.51M
  • Feb 29, 2024: Shares held short 2.98M
  • Mar 15, 2024: Shares held short 3.00M
  • Mar 28, 2024: Shares held short 3.59M
  • Apr 15, 2024: Shares held short 3.15M
  • Apr 30, 2024: Shares held short 2.78M
  • May 15, 2024: Shares held short 2.77M
  • May 31, 2024: Shares held short 2.53M
  • Jun 14, 2024: Shares held short 3.12M
  • Jun 28, 2024: Shares held short 4.80M
  • Jul 15, 2024: Shares held short 3.88M
  • Jul 31, 2024: Shares held short 3.60M
  • Aug 15, 2024: Shares held short 3.35M
  • Aug 30, 2024: Shares held short 3.38M
  • Sep 13, 2024: Shares held short 3.53M
  • Sep 30, 2024: Shares held short 5.59M
  • Oct 15, 2024: Shares held short 4.89M
  • Oct 31, 2024: Shares held short 6.82M
  • Nov 15, 2024: Shares held short 6.45M
  • Nov 29, 2024: Shares held short 6.93M
  • Dec 13, 2024: Shares held short 7.05M
  • Dec 31, 2024: Shares held short 8.21M
  • Jan 15, 2025: Shares held short 8.62M
  • Jan 31, 2025: Shares held short 9.40M
  • Feb 14, 2025: Shares held short 9.54M
  • Feb 28, 2025: Shares held short 9.16M
  • Mar 14, 2025: Shares held short 8.34M
  • Mar 31, 2025: Shares held short 9.94M
  • Apr 15, 2025: Shares held short 11.67M
  • Apr 30, 2025: Shares held short 13.24M
  • May 15, 2025: Shares held short 15.45M
  • May 30, 2025: Shares held short 15.03M
  • Jun 13, 2025: Shares held short 14.88M
  • Jun 30, 2025: Shares held short 15.80M
  • Jul 15, 2025: Shares held short 16.41M
  • Jul 31, 2025: Shares held short 16.08M
  • Aug 15, 2025: Shares held short 16.75M
  • Aug 29, 2025: Shares held short 17.32M
  • Sep 15, 2025: Shares held short 18.04M
  • Sep 30, 2025: Shares held short 15.85M
  • Oct 15, 2025: Shares held short 13.14M
  • Oct 31, 2025: Shares held short 13.37M
  • Nov 14, 2025: Shares held short 15.41M
  • Nov 28, 2025: Shares held short 16.03M
  • Dec 15, 2025: Shares held short 14.69M
  • Dec 31, 2025: Shares held short 14.69M
  • Jan 15, 2026: Shares held short 15.19M
  • Jan 30, 2026: Shares held short 15.18M
  • Feb 13, 2026: Shares held short 15.25M
  • Feb 27, 2026: Shares held short 13.65M
  • Mar 13, 2026: Shares held short 13.41M
  • Mar 31, 2026: Shares held short 13.21M
  • Apr 15, 2026: Shares held short 13.35M
  • Apr 30, 2026: Shares held short 16.72M
  • May 15, 2026: Shares held short 17.77M
  • May 29, 2026: Shares held short 18.53M
  • Jun 15, 2026: Shares held short 18.15M
  • Jun 30, 2026: Shares held short 20.90M
  • Jul 15, 2026: Shares held short 16.85M
  • Jul 31, 2026: Shares held short 16.40M
  • Aug 14, 2026: Shares held short 16.20M
  • Aug 31, 2026: Shares held short 16.28M
  • Sep 15, 2026: Shares held short 17.64M
  • Sep 30, 2026: Shares held short 18.56M
  • Oct 15, 2026: Shares held short 21.17M

As brokers report them to the regulator twice a month, mid-month and at month end, published about eight business days later. A short position is shares sold borrowed and not yet bought back. The share count is the one the company's market value is figured on, from its filings. Days to cover is the shares held short over the average daily volume of the weeks between two reports.

Short sales in daily trading46.8% of the shares in the last 14 sessions' reported trades were short sales.

In the last 14 sessions, 46.8% of the shares in the reported trades were short sales, against 43.5% in the 14 before.

Last 14 sessionsNov 2, 2026 – Nov 19, 2026
46.8%
The 14 beforeOct 13, 2026 – Oct 30, 2026
43.5%
Change
+3.3 pts
Short sales a dayon average, of 1.05M shares
491.7K
More than atof 3,666 US-listed companies, same days
37%
Median of alleight in ten from 34.5% to 63.8%
50.4%
  • Oct 13, 2026: Short sales 46.2%
  • Oct 14, 2026: Short sales 38.9%
  • Oct 15, 2026: Short sales 37.9%
  • Oct 16, 2026: Short sales 46.7%
  • Oct 19, 2026: Short sales 38.9%
  • Oct 20, 2026: Short sales 50.4%
  • Oct 21, 2026: Short sales 52.1%
  • Oct 22, 2026: Short sales 39.4%
  • Oct 23, 2026: Short sales 46%
  • Oct 26, 2026: Short sales 53.1%
  • Oct 27, 2026: Short sales 37.9%
  • Oct 28, 2026: Short sales 34.4%
  • Oct 29, 2026: Short sales 41.6%
  • Oct 30, 2026: Short sales 48.6%
  • Nov 2, 2026: Short sales 42.3%
  • Nov 3, 2026: Short sales 42.5%
  • Nov 4, 2026: Short sales 43.2%
  • Nov 5, 2026: Short sales 40.1%
  • Nov 6, 2026: Short sales 44.5%
  • Nov 9, 2026: Short sales 41.6%
  • Nov 10, 2026: Short sales 51%
  • Nov 11, 2026: Short sales 44.3%
  • Nov 12, 2026: Short sales 56.7%
  • Nov 13, 2026: Short sales 51.2%
  • Nov 16, 2026: Short sales 58.9%
  • Nov 17, 2026: Short sales 50%
  • Nov 18, 2026: Short sales 50.7%
  • Nov 19, 2026: Short sales 49.7%

This is not the number of shares sold short today: it measures short sales within each day's trading, and only trades made off the exchanges. Much of it is market makers, who sell shares they do not have to fill buyers' orders and cover soon after, so for a heavily traded stock the share is often around half.

What the insiders hold

The shares each insider reports holding after their latest trade (Form 4), for those who traded on the market in the last three years.

56.30M Insiders' shares29.27% Of the company
  • Ra Capital Management, L.p.Director,TenPercentOwner
    Directly8.81M
  • Peter KolchinskyDirector,TenPercentOwner
    Directly–
  • Ken TakanashiDirector
    Directly9.64M
  • Gregory L. VerdineDirector
    Directly275.9K
  • Heidi L WagnerDirector
    Directly55.6K
  • Mark CorriganDirector
    Directly39.5K
  • Aik Na TanDirector
    Directly35.7K
  • Christian O HenryDirector
    Directly23.4K
  • Adrian RawcliffeDirector
    Directly10.7K

A lower bound: it counts only the 9 officers and directors with a market trade since Nov 21, 2023. Anyone who neither bought nor sold since is not here, whatever they hold. The share is against the share count on the latest 10-K's cover.

The ETFs that hold it

Which of the 345 US equity ETFs we track hold the stock, and at what weight, from the funds' N-PORT filings.

18 ETFs holding it0.20% The largest weight (IHE)
  • IHEiShares U.S. Pharmaceuticals ETF
    Weight in the fund0.20%
  • IWCiShares Micro-Cap ETF
    Weight in the fund0.18%
  • IBBiShares Biotechnology ETF
    Weight in the fund0.08%
  • IWNiShares Russell 2000 Value ETF
    Weight in the fund0.05%
  • IWMiShares Russell 2000 ETF
    Weight in the fund0.03%
  • VTWOVanguard Russell 2000 Index Fund
    Weight in the fund0.02%
  • SCHASchwab U.S. Small-Cap ETF
    Weight in the fund0.02%
  • FESMFidelity Enhanced Small Cap Core ETF
    Weight in the fund0.01%
  • DFASDimensional U.S. Small Cap ETF
    Weight in the fund0.01%
  • VXFVanguard Extended Market Index Fund
    Weight in the fund0.01%

18 of the 345 ETFs we track, not of every ETF on the market. The ten largest weights. Positions as each fund filed them in its latest N-PORT.

Institutional investors by quarter

Every manager that reports positions to the SEC (Form 13F), quarter by quarter: how many hold the stock, how many shares and dollars between them, and who entered, left, added or trimmed during the quarter.

239 Managers, Q2 2026$1.1B Value of their positions
  • Q3 2025: Managers 191
  • Q4 2025: Managers 220
  • Q1 2026: Managers 232
  • Q2 2026: Managers 239

Institutional investors by quarter

The fund managers holding WVE, quarter by quarter, from Q4 2015 to Q2 2025, 39 more quarters

Part of Ploutos Investor, €9.99 a month

See the plans

Sign in with a free account to see the last 12 quarters.

Q2 2026: 239 managers held 183M shares, worth $1.1B. During the quarter 51 opened a position, 44 closed one, 97 added and 53 trimmed.

The largest holders, Q2 2026

  • Ra Capital Management
    In the quarter
  • BlackRock
    In the quarter+36%
  • Gsk
    In the quarter
  • Maverick Capital
    In the quarter+1.1%
  • Driehaus Capital Management
    In the quarter+0.2%
  • Primecap Management
    In the quarter+11%
  • 683 Capital Management
    In the quarter+1.0%
  • FMR
    In the quarter-5.2%
  • State Street
    In the quarter+32%
  • Readystate Asset Management
    In the quarter

From the SEC's Form 13F data sets, Q3 2025 to Q2 2026: the long positions of every manager with more than $100 million under management, as filed up to 45 days after each quarter end. Short positions and options are not in them. Shares as reported each quarter, not adjusted for splits. The stock is matched by its CUSIP, through the SEC's fails-to-deliver files.

Pay against performance, the say-on-pay vote, buybacks by quarter and trading plans are read for S&P 500 companies only.

The full analysis

What do Wave Life Sciences's filings show?

Who buys and sells is one part of Wave Life Sciences's picture. The full Ploutos AI analysis reads everything the company has filed and shows what stands behind it, with a source for every figure.

  • A fair value range built from the filings
  • Earnings quality, debt and red flags
  • Insider and institutional moves
  • The case for and the case against

Questions about WVE's shareholders

Didn't find what you were looking for?

Ask us
Have WVE's insiders bought or sold?

From Aug 13, 2026 to Oct 7, 2026 Wave Life Sciences's insiders bought 0 and sold $135.1K of shares on the market. 100% of the sales were under set 10b5-1 plans.

Which well-known managers hold WVE?

7 of the managers we track held the shares on Sep 30, 2026. The largest position was D.E. Shaw's, worth $9.4M.

Is every insider transaction a purchase or a sale?

No. Many are part of their pay: share awards, option exercises and shares the company keeps for the tax. Only code P is a purchase with their own money, and code S a sale on the market.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

The figures come from the company's SEC filings and the share price, and describe what it has reported. They are not a score or a fair value.